Stock A102940 KOLON LIFE SCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Kolon Life Science Inc.

Equities

A102940

KR7102940004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
22,400 KRW +0.22% Intraday chart for Kolon Life Science Inc. +1.13% -12.84%
Mar. 20 Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 2.0068 billion in funding from Kolon Life Science Inc.
CI
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Kolon Life Science Inc.(KOSDAQ:A102940) added to S&P Global BMI Index
CI
Kolon Life Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Kolon Biotech, Inc. announced that it has received KRW 5.112 billion in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 5.112 billion in funding from Kolon Life Science Inc.
CI
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 994 million in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 1.5 billion in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 1.005 billion in funding from Kolon Life Science Inc.
CI
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 2.511 billion in funding from Kolon Life Science Inc.
CI
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 2.499 billion in funding from Kolon Life Science Inc.
CI
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Kolon Biotech, Inc. announced that it has received KRW 5.562 billion in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it expects to receive KRW 5.562 billion in funding from Kolon Life Science Inc.
CI
Kolon Biotech, Inc. announced that it has received KRW 5.06 billion in funding from Kolon Life Science Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A102940 Stock
  4. News Kolon Life Science Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW